Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of RO7062931in Healthy Volunteers and Subjects With Chronic Hepatitis B [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety, tolerability, pharmacokinetics and pharmacodynamics of RO7062931 in healthy volunteers and chronic hepatitis B patients has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• RO7062931

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Chronic Hepatitis B | Phase 1 | Status: COMPLETED | Results posted: 2020-12-24